The interplay of CD150 and CD180 receptor pathways contribute to the pathobiology of chronic lymphocytic leukemia B cells by selective inhibition of Akt and MAPK signaling

Gordiienko, Inna; Shlapatska, Larysa; Kholodniuk, Valeriia; Sklyarenko, Lilia; Gluzman, Daniel F.; Clark, Edward A.; Sidorenko, Svetlana P.
October 2017
PLoS ONE;10/05/2017, Vol. 12 Issue 10, p1
Academic Journal
Cell surface expression of CD150 and CD180 receptors in chronic lymphocytic leukemia (CLL) associates with mutational IGHV status and favourable prognosis. Here we show a direct correlation between cell surface expression and colocalization of these receptors on CLL B cells. In the absence of CD150 and CD180 on the cell surface both receptors were expressed in the cytoplasm. The CD150 receptor was colocalized with markers of the endoplasmic reticulum, the Golgi apparatus and early endosomes. In contrast, CD180 was detected preferentially in early endosomes. Analysis of CD150 isoforms differential expression revealed that regardless of CD150 cell surface expression the mCD150 isoform with two ITSM signaling motifs was a predominant CD150 isoform in CLL B cells. The majority of CLL cases had significantly elevated expression level of the soluble sCD150, moreover CLL B cells secrete this isoform. CD150 or CD180 crosslinking on CLL B cells alone led to activation of Akt, mTORC1, ERK1/2, p38MAPK and JNK1/2 networks. Both CD150 and CD180 target the translation machinery through mTOR independent as well as mTOR dependent pathways. Moreover, both these receptors transmit pro-survival signals via Akt-mediated inhibition of GSK3β and FOXO1/FOXO3a. Unexpectedly, coligation CD150 and CD180 receptors on CLL B cells led to mutual inhibition of the Akt and MAPK pathways. While CD150 and CD180 coligation resulted in reduced phosphorylation of Akt, ERK1/2, c-Jun, RSK, p70S6K, S6RP, and 4E-BP; it led to complete blocking of mTOR and p38MAPK phosphorylation. At the same time coligation of CD150 and CD40 receptors did not result in Akt and MAPK inhibition. This suggests that combination of signals via CD150 and CD180 leads to blocking of pro-survival pathways that may be a restraining factor for neoplastic CLL B cells propagation in more than 50% of CLL cases where these receptors are coexpressed.


Related Articles

  • Soluble E-cadherin: a critical oncogene modulating receptor tyrosine kinases, MAPK and PI3K/Akt/mTOR signaling. Brouxhon, S M; Kyrkanides, S; Teng, X; Athar, M; Ghazizadeh, S; Simon, M; O'Banion, M K; Ma, L // Oncogene;1/9/2014, Vol. 33 Issue 2, p225 

    E-cadherin, a cell-cell adhesion glycoprotein, is frequently downregulated with tumorigenic progression. The extracellular domain of E-cadherin is cleaved by proteases to generate a soluble ectodomain fragment, termed sEcad, which is elevated in the urine or serum of cancer patients. In this...

  • mTORC2 Is Required for Rit-Mediated Oxidative Stress Resistance. Cai, Weikang; Andres, Douglas A. // PLoS ONE;Dec2014, Vol. 9 Issue 12, p1 

    Rit, a member of the Ras family of GTPases, has been shown to promote cell survival in response to oxidative stress, in part by directing an evolutionarily conserved p38 MAPK-Akt survival cascade. Aberrant Rit signaling has recently been implicated as a driver mutation in human cancer, adding...

  • ER Stress Induces Anabolic Resistance in Muscle Cells through PKB-Induced Blockade of mTORC1. Deldicque, Louise; Bertrand, Luc; Patton, Amy; Francaux, Marc; Baar, Keith // PLoS ONE;2011, Vol. 6 Issue 6, p1 

    Background: Anabolic resistance is the inability to increase protein synthesis in response to an increase in amino acids following a meal. One potential mediator of anabolic resistance is endoplasmic reticulum (ER) stress. The purpose of the present study was to test whether ER stress impairs...

  • Mutations driving CLL and their evolution in progression and relapse. Landau, Dan A.; Tausch, Eugen; Taylor-Weiner, Amaro N.; Stewart, Chip; Reiter, Johannes G.; Bahlo, Jasmin; Kluth, Sandra; Bozic, Ivana; Lawrence, Mike; Böttcher, Sebastian; Carter, Scott L.; Cibulskis, Kristian; Mertens, Daniel; Sougnez, Carrie L.; Rosenberg, Mara; Hess, Julian M.; Edelmann, Jennifer; Kless, Sabrina; Kneba, Michael; Ritgen, Matthias // Nature;10/22/2015, Vol. 526 Issue 7574, p525 

    Which genetic alterations drive tumorigenesis and how they evolve over the course of disease and therapy are central questions in cancer biology. Here we identify 44 recurrently mutated genes and 11 recurrent somatic copy number variations through whole-exome sequencing of 538 chronic...

  • Cyclin-Dependent Kinase Inhibitor P1446A Induces Apoptosis in a JNK/p38 MAPK-Dependent Manner in Chronic Lymphocytic Leukemia B-Cells. Paiva, Cody; Godbersen, J. Claire; Soderquist, Ryan S.; Rowland, Taylor; Kilmarx, Sumner; Spurgeon, Stephen E.; Brown, Jennifer R.; Srinivasa, Sreesha P.; Danilov, Alexey V. // PLoS ONE;11/25/2015, Vol. 10 Issue 11, p1 

    CDK (cyclin-dependent kinase) inhibitors have shown remarkable activity in CLL, where its efficacy has been linked to inhibition of the transcriptional CDKs (7 and 9) and deregulation of RNA polymerase and short-lived pro-survival proteins such as MCL1. Furthermore, ER (endoplasmic reticulum)...

  • Dual Pharmacological Targeting of the MAP Kinase and PI3K/mTOR Pathway in Preclinical Models of Colorectal Cancer. Pitts, Todd M.; Newton, Timothy P.; Bradshaw-Pierce, Erica L.; Addison, Rebecca; Arcaroli, John J.; Klauck, Peter J.; Bagby, Stacey M.; Hyatt, Stephanie L.; Purkey, Alicia; Tentler, John J.; Tan, Aik Choon; Messersmith, Wells A.; Eckhardt, S. Gail; Leong, Stephen // PLoS ONE;Nov2014, Vol. 9 Issue 11, p1 

    Background: The activation of the MAPK and PI3K/AKT/mTOR pathways is implicated in the majority of cancers. Activating mutations in both of these pathways has been described in colorectal cancer (CRC), thus indicating their potential as therapeutic targets. This study evaluated the combination...

  • The Predominant Protective Effect of Tianeptine Over Other Antidepressants in Models of Neuronal Apoptosis: The Effect Blocked by Inhibitors of MAPK/ERK1/2 and PI3-K/Akt Pathways. Jantas, D.; Krawczyk, S.; Lason, W. // Neurotoxicity Research;Feb2014, Vol. 25 Issue 2, p208 

    Tianeptine (Tian) possesses neuroprotective potential, however, little is known about the effect of this drug in models of neuronal apoptosis. In the present study, we aimed (1) to compare the neuroprotective capacities of some antidepressants (ADs) in the models of staurosporine (St)- and...

  • Time-Dependent Modulation of Mitogen Activated Protein Kinases and AKT in Rat Hippocampus and Cortex in the Pilocarpine Model of Epilepsy. Lopes, Mark; Soares, Flávia; Mello, Nelson; Nunes, Jean; Cordova, Fabiano; Walz, Roger; Leal, Rodrigo // Neurochemical Research;Sep2012, Vol. 37 Issue 9, p1868 

    The epileptogenesis may involve a variety of signaling events that culminate with synaptic reorganization. Mitogen-activated protein kinases (MAPKs) and AKT may be activated by diverse stimulus including neurotransmitter, oxidative stress, growth factors and cytokines and are involved in...

  • Restoration of LRIG1 suppresses bladder cancer cell growth by directly targeting EGFR activity. Lei Chang; Runlin Shi; Tao Yang; Fan Li; Guohao Li; Yonglian Guo; Bin Lang; Weimin Yang; Qianyuan Zhuang; Hua Xu // Journal of Experimental & Clinical Cancer Research (17569966);2013, Vol. 32 Issue 1, p1 

    Background Recently, leucine-rich repeats and immunoglobulin-like domains 1 (LRIG1), a negative regulator of EGFR, was discovered is a novel agent for suppressing bladder cancer. The aim of this study was to investigate the impact of LRIG1 on the biological features of aggressive bladder cancer...

  • Endosulfan induces COX-2 expression via NADPH oxidase and the ROS, MAPK, and Akt pathways. Kim, Hyung; Kim, Young; Park, Jin; Khanal, Tilak; Choi, Jae; Do, Minh; Jin, Sun; Han, Eun; Chung, Young; Jeong, Hye // Archives of Toxicology;Nov2015, Vol. 89 Issue 11, p2039 

    Endosulfan (1,4,5,6,7,7-hexachloro-8,9,10-trinorborn-5-en-2,3-ylenebismet-hylene) is correlated with endocrine disruption, reproductive, and immune dysfunctions. Recently, endosulfan was shown to have an effect on inflammatory pathways, but its influence on cyclooxygenase-2(COX-2) expression is...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics